1. Metabolic Enzyme/Protease NF-κB Apoptosis Immunology/Inflammation
  2. HIF/HIF Prolyl-Hydroxylase IKK NF-κB Apoptosis Reactive Oxygen Species (ROS)
  3. HIF-1α-IN-8

HIF-1α-IN-8 is an orally active HIF-1α inhibitor, with an IC50 of 2.02 μM. HIF-1α-IN-8 significantly suppresses the expression of inflammation factors of IL-6 and NO, reduces hypoxia-induced ROS production and apoptosis in C8-D1A cells. HIF-1α-IN-8 inhibits HIF-1α/IKKα/NF-κB signaling pathway and reduces the expression of blood-brain barrier permeability-related proteins. HIF-1α-IN-8 reduces brain water content and oxidative stress level in mice with high altitude cerebral edema (HACE) model. HIF-1α-IN-8 can be used for the study of high altitude cerebral edema (HACE).

For research use only. We do not sell to patients.

HIF-1α-IN-8

HIF-1α-IN-8 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All HIF/HIF Prolyl-Hydroxylase Isoform Specific Products:

View All IKK Isoform Specific Products:

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

HIF-1α-IN-8 is an orally active HIF-1α inhibitor, with an IC50 of 2.02 μM. HIF-1α-IN-8 significantly suppresses the expression of inflammation factors of IL-6 and NO, reduces hypoxia-induced ROS production and apoptosis in C8-D1A cells. HIF-1α-IN-8 inhibits HIF-1α/IKKα/NF-κB signaling pathway and reduces the expression of blood-brain barrier permeability-related proteins. HIF-1α-IN-8 reduces brain water content and oxidative stress level in mice with high altitude cerebral edema (HACE) model. HIF-1α-IN-8 can be used for the study of high altitude cerebral edema (HACE)[1].

IC50 & Target[1]

HIF-1α

2.02 μM (IC50)

IKKα

 

In Vitro

HIF-1α-IN-8 (Compound N41) (20 μM, 48 h) suppresses the secretion of inflammatory factors IL-6 and NO in C8-D1A cells[1].
HIF-1α-IN-8 (5-50 μM, 12 h) reduces hypoxia-induced ROS production and apoptosis in C8-D1A cells[1].
HIF-1α-IN-8 (5-20 μM, 24 h) inhibits the expression of key proteins (HIF-1α, IKKα, p65, IκBα) in the HIF-1α/IKKα/NF-κB signaling pathway and reduces the expression of blood-brain barrier permeability-related proteins MMP-9 and AQP-4 in C8-D1A cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: C8-D1A cells
Concentration: 5, 10, 20, 50 μM
Incubation Time: 12 h
Result: Reduced apoptosis in C8-D1A cells.

Western Blot Analysis[1]

Cell Line: C8-D1A cells
Concentration: 5, 10, 20 μM
Incubation Time: 24 h
Result: Inhibited the expression of key proteins (HIF-1α, IKKα, p65, IκBα) in the HIF-1α/IKKα/NF-κB signaling pathway.
Reduced the expression of blood-brain barrier permeability-related proteins MMP-9 and AQP-4 in C8-D1A cells.
In Vivo

HIF-1α-IN-8 (Compound N41) (25-100 mg/kg, i.g., once daily, 3 days) reduces brain water content and oxidative stress level in mice with high altitude cerebral edema (HACE) model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Adult male C57BL/6 mice were intraperitoneally injected with 0.5 mg/kg LPS (HY-D1056) and after 30 min of adaptation, mice were placed in a ProOx-810 Animal Low-Pressure Oxygen Control System to simulate a 7000 m high-altitude environment for 12 h to establish the HACE model[1]
Dosage: 25 mg/kg, 50 mg/kg, 100 mg/kg
Administration: i.g. once daily, 3 days
Result: Reduced weight loss in a dose-dependent manner.
Decreased brain water content (BWC) dose-dependently.
Regulated oxidative stress in brain tissue.
Suppressed inflammatory factor (IL-6, TNF-α)levels.
Alleviated brain tissue pathological damage.
Inhibited protein expression in the HIF-1α/IKKα/NF-κB signaling pathway.
Molecular Weight

523.55

Formula

C29H30FNO7

SMILES

O=C(NC1=CC=C(C2=CC=C(CCO[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C2)C=C1)/C=C/C4=CC=CC=C4F

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
HIF-1α-IN-8
Cat. No.:
HY-175521
Quantity:
MCE Japan Authorized Agent: